IRF3 and cancer: This is consistent with the sensing of genomic damage of cancer cells by fibroblasts, which resulted from transcytosis of cytoplasm from cancer cells into neighboring fibroblasts and activation of the stimulator of interferon genes–interferon regulatory factor 3 pathway51.